PUBLISHED BY
M.M. SHARMA
- Advocate , Delhi High Court & Supreme Court of India
- Head-Competition Law
- Vaish Associates Advocates
- Former- Head-Legal ( In House) - Jindal Steel & Power Limited (JSPL)
- Former -Additional Registrar , Competition Commission of India (CCI)
- Ministry of Corporate Affairs , Govt .of India in the rank of Director to the Govt of India
- Former- Law Officer /Judge-Advocate , Indian Coast Guard (ICG), Ministry of Defence , Government of India in the rank of Commandant (JG)
- Former -Municipal Prosecutor /Dy Law Officer ,New Delhi Municipal Council (NDMC), New Delhi
Latest Articles
Regulating Medicine Pricing in India: Is the Supreme Court’s Recent Intervention Alone Sufficient? An Appraisal (Part II-Concluding )
November 13, 2026• CCI, Competition Law & Antitrust, miscellaneous, News and Events, Pharmaceuticals, Supreme Court, Supreme Court of India, Views
Regulating Medicine Pricing in India: Supreme Court’s Recent Intervention—Does the CCI Have a Role? An Appraisal (Part I)
November 10, 2026• Antitrust, Competition Law & Antitrust, miscellaneous, Pharmaceuticals, Supreme Court of India, Views
When legislation frustrates litigation: CCI Closes Its Real-Money Gaming Probe Against Google
September 14, 2026• Abuse of Dominance, Antitrust, Big Tech, E-Commerce & Online Market, Supreme Court of India
A Cartel Without a Penalty? The Muthoot Finance Order and the Deterrence Question.
September 13, 2026• Antitrust, Cartels & Anti Competitive Agreement, CCI, Competition Law & Antitrust
Can a Manufacturer Escape Cartel Liability for the Conduct of Its Liaison Agent?
September 13, 2026• Antitrust, Cartels & Anti Competitive Agreement, CCI, Competition Law & Antitrust
When does a “Tailor-Made” Tender Become a Competition Law Problem?Is suspicion alone sufficient ?
September 13, 2026• miscellaneous
Regulating Medicine Pricing in India: Is the Supreme Court’s Recent Intervention Alone Sufficient? An Appraisal (Part II-Concluding )
November 13, 2026• CCI, Competition Law & Antitrust, miscellaneous, News and Events, Pharmaceuticals, Supreme Court, Supreme Court of India, Views
India’s New E-Commerce Rules: From Consumer Protection to Algorithmic Transparency
September 13, 2026• Abuse of Dominance, Big Tech, Digital Competition, E-Commerce & Online Market, miscellaneous, News and Events, Views
Regulating Medicine Pricing in India: Is the Supreme Court’s Recent Intervention Alone Sufficient? An Appraisal (Part II-Concluding )
November 13, 2026• CCI, Competition Law & Antitrust, miscellaneous, News and Events, Pharmaceuticals, Supreme Court, Supreme Court of India, Views
Regulating Medicine Pricing in India: Is the Supreme Court’s Recent Intervention Alone Sufficient? An Appraisal (Part II-Concluding )
November 13, 2026• CCI, Competition Law & Antitrust, miscellaneous, News and Events, Pharmaceuticals, Supreme Court, Supreme Court of India, Views
Regulating Medicine Pricing in India: Supreme Court’s Recent Intervention—Does the CCI Have a Role? An Appraisal (Part I)
November 10, 2026• Antitrust, Competition Law & Antitrust, miscellaneous, Pharmaceuticals, Supreme Court of India, Views
When legislation frustrates litigation: CCI Closes Its Real-Money Gaming Probe Against Google
September 14, 2026• Abuse of Dominance, Antitrust, Big Tech, E-Commerce & Online Market, Supreme Court of India
Minority investment or strategic acquisition -CCI expands scope for “Gun Jumping”.
February 6, 2025• Mergers
INDIA REVAMPS ITS MERGER CONTROL PROVISONS -INTRODUCES DEAL VALUE THRESHOLD
September 20, 2024• Mergers
Minority investment or strategic acquisition -CCI expands scope for “Gun Jumping”.
February 6, 2025• Mergers
INDIA REVAMPS ITS MERGER CONTROL PROVISONS -INTRODUCES DEAL VALUE THRESHOLD
September 20, 2024• Mergers
Regulating Medicine Pricing in India: Is the Supreme Court’s Recent Intervention Alone Sufficient? An Appraisal (Part II-Concluding )
November 13, 2026• CCI, Competition Law & Antitrust, miscellaneous, News and Events, Pharmaceuticals, Supreme Court, Supreme Court of India, Views
India’s New E-Commerce Rules: From Consumer Protection to Algorithmic Transparency
September 13, 2026• Abuse of Dominance, Big Tech, Digital Competition, E-Commerce & Online Market, miscellaneous, News and Events, Views
Regulating Medicine Pricing in India: Is the Supreme Court’s Recent Intervention Alone Sufficient? An Appraisal (Part II-Concluding )
November 13, 2026• CCI, Competition Law & Antitrust, miscellaneous, News and Events, Pharmaceuticals, Supreme Court, Supreme Court of India, Views
Regulating Medicine Pricing in India: Supreme Court’s Recent Intervention—Does the CCI Have a Role? An Appraisal (Part I)
November 10, 2026• Antitrust, Competition Law & Antitrust, miscellaneous, Pharmaceuticals, Supreme Court of India, Views
When legislation frustrates litigation: CCI Closes Its Real-Money Gaming Probe Against Google
September 14, 2026• Abuse of Dominance, Antitrust, Big Tech, E-Commerce & Online Market, Supreme Court of India
Regulating Medicine Pricing in India: Is the Supreme Court’s Recent Intervention Alone Sufficient? An Appraisal (Part II-Concluding )
November 13, 2026• CCI, Competition Law & Antitrust, miscellaneous, News and Events, Pharmaceuticals, Supreme Court, Supreme Court of India, Views
Regulating Medicine Pricing in India: Supreme Court’s Recent Intervention—Does the CCI Have a Role? An Appraisal (Part I)
November 10, 2026• Antitrust, Competition Law & Antitrust, miscellaneous, Pharmaceuticals, Supreme Court of India, Views
When legislation frustrates litigation: CCI Closes Its Real-Money Gaming Probe Against Google
September 14, 2026• Abuse of Dominance, Antitrust, Big Tech, E-Commerce & Online Market, Supreme Court of India
Categories
- Abuse of Dominance 10
- Antitrust 190
- Big Tech 7
- Cartels & Anti Competitive Agreement 4
- CCI 12
- COMPAT 1
- Competition Law & Antitrust 12
- Delhi High Court 1
- Digital Competition 5
- E-Commerce & Online Market 3
- Events 1
- High Courts 1
- Mergers 29
- miscellaneous 86
- National Competition Policy 1
- News and Events 177
- Pharmaceuticals 3
- Supreme Court 2
- Supreme Court of India 4
- Views 5
Recent Posts
- Regulating Medicine Pricing in India: Is the Supreme Court’s Recent Intervention Alone Sufficient? An Appraisal (Part II-Concluding ) November 13, 2026
- Regulating Medicine Pricing in India: Supreme Court’s Recent Intervention—Does the CCI Have a Role? An Appraisal (Part I) November 10, 2026
- When legislation frustrates litigation: CCI Closes Its Real-Money Gaming Probe Against Google September 14, 2026
- A Cartel Without a Penalty? The Muthoot Finance Order and the Deterrence Question. September 13, 2026
- Can a Manufacturer Escape Cartel Liability for the Conduct of Its Liaison Agent? September 13, 2026
- Contact Us
Competitionlawyer
The Antitrust and Competition Law Blog is an initiative of Mr. Man Mohan Sharma @ Mr MM Sharma . Mr. Sharma is an advocate having a vast experience of over 35 years in matters of commercial litigation and advisory, particularly in Antitrust/ Competition Law and Policy in India.